These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33616679)

  • 1. V-domain Ig suppressor of T cell activation (VISTA) inhibition is a new approach to cancer therapy: a Bibliometric study.
    Ait Boujmia OK
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1057-1065. PubMed ID: 33616679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.
    Huang T; Ren X; Tang X; Wang Y; Ji R; Guo Q; Ma Q; Zheng Y; Hu Z; Zhou Y
    Front Immunol; 2024; 15():1427380. PubMed ID: 39188712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of hydrogels in cancer immunotherapy: a bibliometric analysis.
    Liu X; Zhou Q; Yang Y; Chen E
    Front Immunol; 2024; 15():1433050. PubMed ID: 39192983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.
    Huang X; Zhang X; Li E; Zhang G; Wang X; Tang T; Bai X; Liang T
    J Hematol Oncol; 2020 Jun; 13(1):83. PubMed ID: 32600443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bibliometric analysis of six nursing journals from the Web of Science, 2012-2017.
    Giménez-Espert MDC; Prado-Gascó VJ
    J Adv Nurs; 2019 Mar; 75(3):543-554. PubMed ID: 30289557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.
    ElTanbouly MA; Croteau W; Noelle RJ; Lines JL
    Semin Immunol; 2019 Apr; 42():101308. PubMed ID: 31604531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VISTA: A Novel Checkpoint for Cancer Immunotherapy.
    Gao Y; He Y; Tang Y; Chen ZS; Qu M
    Drug Discov Today; 2024 Jul; 29(7):104045. PubMed ID: 38797321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.
    Zheng W; Wu Y; Wang Y; Cheng J; Shen W
    Medicine (Baltimore); 2023 Jul; 102(27):e34228. PubMed ID: 37417594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bibliometric analysis of classic publications in web of science category of orthopedics.
    Li Y; Xu G; Long X; Ho YS
    J Orthop Surg Res; 2019 Jul; 14(1):227. PubMed ID: 31324248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
    Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
    Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The top 100 highly cited articles on osteoporosis from 1990 to 2019: a bibliometric and visualized analysis.
    Gao Q; Zhang C; Wang J; Wei Q; Wei Q; Miyamoto A; Zhu S; He C
    Arch Osteoporos; 2020 Sep; 15(1):144. PubMed ID: 32935223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and Visibility of "Digital Health" as a Keyword in Articles by JMIR Publications in the New Millennium: Bibliographic-Bibliometric Analysis.
    Ahmadvand A; Kavanagh D; Clark M; Drennan J; Nissen L
    J Med Internet Res; 2019 Dec; 21(12):e10477. PubMed ID: 31855190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.
    Yuan L; Tatineni J; Mahoney KM; Freeman GJ
    Trends Immunol; 2021 Mar; 42(3):209-227. PubMed ID: 33495077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 100 most-cited articles in urological surgery: A bibliometric analysis.
    He L; Fang H; Wang X; Wang Y; Ge H; Li C; Chen C; Wan Y; He H
    Int J Surg; 2020 Mar; 75():74-79. PubMed ID: 31926329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy.
    Lines JL; Sempere LF; Broughton T; Wang L; Noelle R
    Cancer Immunol Res; 2014 Jun; 2(6):510-7. PubMed ID: 24894088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bibliometric Analysis of Neurology Articles Published in General Medicine Journals.
    Wilson M; Sampson M; Barrowman N; Doja A
    JAMA Netw Open; 2021 Apr; 4(4):e215840. PubMed ID: 33856477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.
    Hosseinkhani N; Derakhshani A; Shadbad MA; Argentiero A; Racanelli V; Kazemi T; Mokhtarzadeh A; Brunetti O; Silvestris N; Baradaran B
    Front Immunol; 2021; 12():676181. PubMed ID: 34093577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational therapy publications by Australian authors: A bibliometric analysis.
    Brown T; Gutman SA; Ho YS
    Aust Occup Ther J; 2018 Aug; 65(4):249-258. PubMed ID: 29344965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 100 Most-Cited Articles Focused on Ultrasound Imaging: A Bibliometric Analysis.
    Moon JY; Yun EJ; Yoon DY; Choi CS; Seo YL; Cho YK; Lim KJ; Baek S; Hong SJ; Yoon SJ
    Ultraschall Med; 2017 Jun; 38(3):311-317. PubMed ID: 28511228
    [No Abstract]   [Full Text] [Related]  

  • 20. Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022).
    Huang X; Guo J; Wang S; Lin Z; Zhao S; Li W; Wang Y; Zhu C; Lv J; Qiu W
    Hum Vaccin Immunother; 2023 Aug; 19(2):2246498. PubMed ID: 37635349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.